Metabolic Control Analysis in a Cellular Model of Elevated MAO-B: Relevance to Parkinson’s Disease

被引:0
作者
Jyothi K. Mallajosyula
Shankar J. Chinta
Subramanian Rajagopalan
David G. Nicholls
Julie K. Andersen
机构
[1] Buck Institute for Age Research,
来源
Neurotoxicity Research | 2009年 / 16卷
关键词
Mitochondrial dysfunction; Monoamine oxidase B; Hydrogen peroxide; Krebs cycle enzymes; Metabolic control analysis; Reactive oxygen species;
D O I
暂无
中图分类号
学科分类号
摘要
We previously demonstrated that spare respiratory capacity of the TCA cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH) was completely abolished upon increasing levels of MAO-B activity in a dopaminergic cell model system (Kumar et al., J Biol Chem 278:46432–46439, 2003). MAO-B mediated increases in H2O2 also appeared to result in direct oxidative inhibition of both mitochondrial complex I and aconitase. In order to elucidate the contribution that each of these components exerts over metabolic respiratory control as well as the impact of MAO-B elevation on their spare respiratory capacities, we performed metabolic respiratory control analysis. In addition to KGDH, we assessed the activities and substrate-mediated respiration of complex I, pyruvate dehydrogenase (PDH), succinate dehydrogenase (SDH), and mitochondrial aconitase in the absence and presence of complex-specific inhibitors in specific and mixed substrate conditions in mitochondria from our MAO-B elevated cells versus controls. Data from this study indicates that Complex I and KGDH are the most sensitive to inhibition by MAO-B mediated H2O2 generation, and could be instrumental in determining the fate of mitochondrial metabolism in this cellular PD model system.
引用
收藏
页码:186 / 193
页数:7
相关论文
共 50 条
  • [31] Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: Implications for early intervention on disease progression
    Siddiqui, Almas
    Mallajosyula, Jyothi K.
    Rane, Anand
    Andersen, Julie K.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (02) : 444 - 448
  • [32] YKL-40 and the Cellular Metabolic Profile in Parkinson's Disease
    Gevezova, Maria
    Kazakova, Maria
    Trenova, Anastasia
    Sarafian, Victoria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [33] Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography
    Richards, Grayson
    Messer, Juerg
    Waldvogel, Henry J.
    Gibbons, Hannah M.
    Dragunow, Mike
    Faull, Richard L. M.
    Saura, Josep
    BRAIN RESEARCH, 2011, 1370 : 204 - 214
  • [34] In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA2AR antagonists for the treatment of Parkinson's disease
    Boulaamane, Yassir
    Ibrahim, Mahmoud A. A.
    Britel, Mohammed Reda
    Maurady, Amal
    JOURNAL OF INTEGRATIVE BIOINFORMATICS, 2022, 19 (04)
  • [35] Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson's Disease
    Anastassova, Neda
    Aluani, Denitsa
    Hristova-Avakumova, Nadya
    Tzankova, Virginia
    Kondeva-Burdina, Magdalena
    Rangelov, Miroslav
    Todorova, Nadezhda
    Yancheva, Denitsa
    ANTIOXIDANTS, 2022, 11 (05)
  • [36] Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor
    Malmlof, Torun
    Feltmann, Kristin
    Konradsson-Geuken, Asa
    Schneider, Frank
    Alken, Rudolf-Giesbert
    Svensson, Torgny H.
    Schilstrom, Bjorn
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (02) : 259 - 272
  • [37] Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment
    Swati, Amir
    Raza, Amir
    Singh, Bhupendra
    Wadhwa, Pankaj
    CHEMISTRYSELECT, 2025, 10 (01):
  • [38] Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
    Cassarino, DS
    Fall, CP
    Swerdlow, RH
    Smith, TS
    Halvorsen, EM
    Miller, SW
    Parks, JP
    Parker, WD
    Bennett, JP
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1362 (01): : 77 - 86
  • [39] Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation
    He, Qi
    Liu, Jing
    Lan, Jin-Shuai
    Ding, Jiaoli
    Sun, Yongbing
    Fang, Yuanying
    Jiang, Neng
    Yang, Zunhua
    Sun, Liyuan
    Jin, Yi
    Xie, Sai-Sai
    BIOORGANIC CHEMISTRY, 2018, 81 : 512 - 528
  • [40] Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline
    Sturm, Stefan
    Forsberg, Anton
    Nave, Stephane
    Stenkrona, Per
    Seneca, Nicholas
    Varrone, Andrea
    Comley, Robert A.
    Fazio, Patrik
    Jamois, Candice
    Nakao, Ryuji
    Ejduk, Zbigniew
    Al-Tawil, Nabil
    Akenine, Ulrika
    Halldin, Christer
    Andreasen, Niels
    Ricci, Benedicte
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (03) : 382 - 391